Atai Life Sciences Price to Free Cash Flow Ratio 2020-2023 | ATAI
Atai Life Sciences Price to Free Cash Flow Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
2024-04-26 | 1.93 | 0.00 | |
2023-12-31 | 1.41 | $-0.53 | 0.00 |
2023-09-30 | 1.29 | $-0.55 | 0.00 |
2023-06-30 | 1.72 | $-0.66 | 0.00 |
2023-03-31 | 1.81 | $-0.66 | 0.00 |
2022-12-31 | 2.66 | $-0.68 | 0.00 |
2022-09-30 | 3.31 | $-0.65 | 0.00 |
2022-06-30 | 3.64 | $-0.65 | 0.00 |
2022-03-31 | 5.09 | $-0.62 | 0.00 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical - Outpatient & Home Care | $0.323B | $0.000B |
atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Fresenius SE (FSNUY) | Germany | $16.392B | 9.92 |
Quest Diagnostics (DGX) | United States | $14.915B | 15.41 |
DaVita (DVA) | United States | $11.709B | 15.93 |
Chemed (CHE) | United States | $8.472B | 26.30 |
Encompass Health (EHC) | United States | $8.259B | 21.25 |
Elanco Animal Health (ELAN) | United States | $6.552B | 14.90 |
Option Care Health (OPCH) | United States | $5.147B | 19.48 |
RadNet (RDNT) | United States | $3.314B | 96.80 |
Amedisys (AMED) | United States | $2.999B | 21.25 |
LifeStance Health (LFST) | United States | $2.370B | 0.00 |
Astrana Health (ASTH) | United States | $2.057B | 25.68 |
Addus HomeCare (ADUS) | United States | $1.548B | 23.52 |
U.S Physical Therapy (USPH) | United States | $1.516B | 39.30 |
Pennant (PNTG) | United States | $0.624B | 36.46 |
Aveanna Healthcare Holdings (AVAH) | United States | $0.423B | 0.00 |
Daxor (DXR) | United States | $0.046B | 0.00 |
MEDIROM Healthcare Technologies (MRM) | Japan | $0.029B | 0.00 |
ATI Physical Therapy (ATIP) | United States | $0.018B | 0.00 |
Psychemedics (PMD) | United States | $0.015B | 0.00 |
Ontrak (OTRK) | United States | $0.014B | 0.00 |
Novo Integrated Sciences (NVOS) | United States | $0.010B | 0.00 |
IMAC Holdings (BACK) | United States | $0.005B | 0.00 |